This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In the ever-evolving landscape of pharmaceutical manufacturing, modular and automated platforms are spearheading a transformative shift, particularly in the realm of non-biologics. Robotics streamline procedures, while automation addresses critical challenges such as supply chain disruptions and worker safety.
This news incorporates a lot of things currently receiving media attention—data integration and visualization solution that incorporates roboticprocess automation (RPA). It is suited for use in a wide variety of industries, from oil & gas to chemicals and pharmaceuticals. Yokogawa Electric Corp.
D:PLOY automatically discovers and configures all the components in a robotic cell – including any leading collaborative or light industrial robot arm and tools – while also integrating external I/O from sensors and machines. D:PLOY will be available for all common robotic applications, making deployment up to 80% faster.
Smart pharmaceutical manufacturing can do more than drive up productivity. As a result, pharmaceutical companies can help to protect both people and the environment. The future of pharmaceutical manufacturing, also known as Pharma 4.0, is based on data-driven technologies. Pharma 4.0
The global robot vision system market is likely at US$ 2,690.4 In order to improve job efficiency and replace human labour, the market for robots is rising and is anticipated to rise more during the coming year. Key Takeaways from Market Study The global robot vision system market is projected to reach the valuation US$ 7,236.2
Initially focused on traditional pharmaceutical manufacturing, the consortium seeks to accelerate manufacturing transformation in Ireland through ecosystem collaboration. One example of this is the industry-led, government-supported consortium called the Lighthouse Partnership in Disruptive and Sustainable Technologies.
Smart machines and robotics will handle more of the industrial work especially where human intervention would be seen as more dangerous to deploy. With the incubation of robotics and Industry 4.0, With the incubation of robotics and Industry 4.0, Medical plastics deliver a pharmaceutical compound to its target site.
We organize all of the trending information in your field so you don't have to. Join 45,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content